KEVIN RAKIN
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR, PROMOTER, EXECUTIVE OFFICER
DIRECTOR, PROMOTER, EXECUTIVE OFFICER
DIRECTOR
DIRECTOR
KIRK ANDRIANO, RASAPPA ARUMUGHAM, JOSHUA BALTZELL, KELLY BECK, BRIAN CALLAHAN, KRISTEN CASTILLO, PRABHAVATHI FERNANDES, PATRICK FORTUNE, DAVID GILL, PETER GREENLEAF, ADAM GRIDLEY, JOHN JOHNSON, JOHN J. JOHNSON, DANIEL JORGENSEN, UDAY B KOMPELLA, GARHENG KONG, GARHENG KONG, M.D., PH.D, GARHENG KONG, M.D., PH.D., RAMESH KUMAR, MICHAEL LEWIS, JONATHAN LIEBER, KEVIN MCARDLE, SHANKAR MUSUNURI, PATRICK O-DONNELL, MANISH POTTI, PHILIP PRESS, DOMINIC REDFERN, HARRY REIN, SANJAY SUBRAMANIAN, VIJAY TAMMARA, LAURENCE J.B. TARRANT, SUHA TASPOLATOGLU, JUNGE ZHANG
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
KURT ARARBARZIN, CHRISTINE ARASIN, KURT AZARBARZIN, NORA BRENNAN, VINCE BURGASS, VINCE BURGESS, FRANCIS CONWAY, RONALD J. ELLIS JR., RONALD J. ELLIS, JR., ASHLEY FREIDMAN, ASHLEY FRIEDMAN, ANTONY KOBLISH, ADELE OLIVA, ADELE C. OLIVA, MAARTEN PERSENAIRE, CHRISTOPER SMITH, CHRISTOPHER SMITH, PAUL TOUHEY, MATT ZUGA
DIRECTOR
DAVID COLPMAN, LODE DEBRABANDERE, MATTHEW FERGUSON, JEFFREY HAMET, JEFFREY D HAMET, STEVEN HOCHBERG, WILLIAM HOCHBERG, STEVEN HOTCHBERG, MAYBELLE JORDAN, RONALD LLOYD, BRIGID A. MAKES, C. RANDAL MILLS, CHARLES RANDAL MILLS, C. RANDAL MILLS. PH.D., MICHELLE LEROUX WILLIAMS, W. MATTHEW ZUGA, WILLIAM MATTHEW ZUGA
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR, EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
DAVID COLPMAN, LODE DEBRABANDERE, MATTHEW FERGUSON, JEFFREY HAMET, JEFFREY D HAMET, STEVEN HOCHBERG, WILLIAM HOCHBERG, STEVEN HOTCHBERG, MAYBELLE JORDAN, RONALD LLOYD, BRIGID A. MAKES, C. RANDAL MILLS, CHARLES RANDAL MILLS, C. RANDAL MILLS. PH.D., MICHELLE LEROUX WILLIAMS, W. MATTHEW ZUGA, WILLIAM MATTHEW ZUGA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-09-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-12-05
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-09-11
D
OTHER HEALTH CARE
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
DECLINE TO DISCLOSE
Equity
2016-09-29

